HIVClinicalForum
Meeting category
Date(s)
31 May 2017 - 1 Jun 2017
Location
Hong Kong, China
Organizer

Asia-Pacific HIV Clinical Forum 2017

Related Enduring Materials

Enduring Materials
Session 1: HIV Management: State of the Art -
Chairs
Patrick Chung-Ki Li
Patrick Li, MBBS, FHKCP, FHKAM, FRCP, FRCP
Hong Kong Sanatorium and Hospital, Hong Kong SAR, China
Fujie Zhang
Fujie Zhang, MD, PhD
Beijing Ditan Hospital, Capital Medical University, China
Understanding Viral Suppression
Daniel Kuritzkes, MD
Brigham and Women's Hospital / Harvard Medical School, United States
HIV Macroprevention, epidemiology, phylogenics and networks
Charles Boucher, MD, PhD
Erasmus Medical Center, The Netherlands
Session 2 -
Chairs
Daniel Kuritzkes
Daniel Kuritzkes , MD
Harvard Medical School, USA
Ishwar Gilada
Ishwar Gilada, MD, DDV, FCPS
JJ Hospital, Mumbai, India
Clinical Experience with Integrase Inhibitors (not available)
Y.S. Kim
Dr. Yeon-sook Kim
University of Nebraska Medical Cente , USA
Resistance Characteristics of HIV Integrase Inhibitors (not available)
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
Clinical case presentation
Wilson Lam
Dr. Wilson Lam
AIDS Clinical Service, Queen Elizabeth Hospital, Hong Kong
Clinical case presentation
Thana Khawcharoenporn, MD, MSc
Thammasat University, Thailand
Session 3: Drugs to Address Challenging Populations / Special Considerations -
Chairs
Lu, Hongzhou_photo
Hongzhou Lu, MD, PhD
Shanghai Public Health Clinical Center at Fudan University (SHAPHC), China
Thana Khawcharoenporn
Thana Khawcharoenporn, MD, MSc
Thammasat University, Thailand
ARV Side effects and Management
Fujie Zhang, MD, PhD
Beijing Ditan Hospital, Capital Medical University, China
Social Considerations in HIV treatment decisions in Asian population (not available)
Stephane Wen-Wei Ku, MD
Taipei City Hospital Renai, Taiwan
Clinical case presentation (not available)
Saye Khoo, MD, PhD
Royal Liverpool University Hospital; University of Liverpool, United Kingdom
Nai-Ying Ko
Dr. Nai-Ying Ko
National Cheng Kung University Hospital, Taiwan
Clinical case presentation
Ishwar Gilada, MD, DDV, FCPS
AIDS Society of India, India
Session 4: Antiretroviral Treatment Strategies -
Chairs
Charles Boucher
Charles Boucher, MD
Erasmus Medical Center, the Netherlands
Jonathan Schapiro
Jonathan Schapiro, MD
Sheba Medical Center, Israel
2nd line treatment options in Resource Limited Settings (not available)
David Cooper
Dr. David Cooper
The Kirby Institute, Australia
Abstract presentations
Discovery of novel thiazole-1,3,5-triazine conjugates as potent anti-HIV agent via inhibition of Integrase enzyme (not available)
Dr. S. Sirivichayakul, Chulalongkorn University, Thailand
Genotypic Resistance to Integrase inhibitor: a cross sectional study during 2014-2016 in Bangkok, Thailand (not available)
Dr. U. Pratap Singh, Sam Higginbottom University Of Agriculture, Technology & Sciences, India
Antiretroviral Treatment Strategies: Clinical Case Presentation
Chia-Jui Yang
Dr. Chia-Jui Yang
Far Eastern Memorial Hospital, Taiwan
Overview
Welcome

The first edition of the Asia Pacific HIV Clinical Forum was held on 31 May and 1 June 2017 in Hong Kong, preceding the APACC 2017.

The meeting was a success with great lectures and exciting discussions! Thank you to our conference supporter ViiV Healthcare for making this meeting possible and to our endorsers: AIDS Society of the Philippines, HealthHIV, HIV/AIDS Coordinating Committee (HACC), Hong Kong Infection Control Nurses Association (HKICNA), HIV-NAT, Hong Kong Society for HIV Medicine (HKSHM), IAPAC, The Japanese Association for Infectious Diseases, Malaysian Society for HIV Medicine (MASHM) for supporting this meeting!

The Asia Pacific HIV Clinical Forum focused entirely on the Asia Pacific community and Integrase Inhibitors as Integrase Inhibitors are rapidly gaining a central role in the routine care of HIV infected individuals. The HIV Clinical Forum meetings aim at enhancing the clinical skills and research capabilities of HIV healthcare professionals in regard to this unique class of antiretroviral drugs.

The Program Chairs

Background

The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.

Support
Language